Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

White House Reportedly Urged Pfizer and Moderna to License Vaccine Technologies: NY Times

09/22/2021 | 08:29am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
03:38pMODERNA : U.S. administers 408.3 mln doses of COVID-19 vaccines - CDC
RE
04:24aPFIZER : United States Donates 1.6 Million More COVID-19 Pfizer Vaccines to Egypt This is ..
AQ
10/16MODERNA : U.S. administers 407.4 mln doses of COVID-19 vaccines -CDC
RE
10/15PFIZER : States can reserve COVID-19 shots for younger kids next week
AQ
10/15FDA panel recommends J&J COVID-19 booster for all recipients who got first shot
AQ
10/15MODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
10/15PFIZER : FDA panel endorses booster shot for J&J COVID-19 vaccine
AQ
10/15MODERNA : U.S. FDA delays decision on Moderna's COVID-19 vaccine for adolescents - WSJ
RE
10/15PFIZER : FDA panel takes up tough questions on J&J COVID-19 boosters
AQ
10/15MODERNA : U.S. FDA advisers to vote on J&J COVID-19 vaccine booster
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 101 M - -
Net income 2021 18 457 M - -
Net Debt 2021 29 308 M - -
P/E ratio 2021 12,3x
Yield 2021 3,80%
Capitalization 233 B 233 B -
EV / Sales 2021 3,23x
EV / Sales 2022 3,68x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 41,49 $
Average target price 45,72 $
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.13.20%232 621
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283